Sareum Holdings plc (LON:SAR – Get Free Report)’s share price was up 11.7% during mid-day trading on Friday . The stock traded as high as GBX 44.75 ($0.57) and last traded at GBX 43 ($0.55). Approximately 900,265 shares traded hands during mid-day trading, a decline of 10% from the average daily volume of 996,774 shares. The stock had previously closed at GBX 38.50 ($0.49).
Sareum Price Performance
The firm has a 50 day moving average of GBX 34.38 and a 200-day moving average of GBX 37.15. The stock has a market capitalization of £46.96 million, a P/E ratio of -641.67 and a beta of -1.03.
About Sareum
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Further Reading
- Five stocks we like better than Sareum
- Manufacturing Stocks Investing
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- How is Compound Interest Calculated?
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
